Page last updated: 2024-11-04

sulfamethoxypyridazine and Cataract

sulfamethoxypyridazine has been researched along with Cataract in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HARLEY, JD2
FARRAR, JF2
GRAY, JB1
DUNLOP, IC1

Other Studies

2 other studies available for sulfamethoxypyridazine and Cataract

ArticleYear
AROMATIC DRUGS AND CONGENITAL CATARACTS.
    Lancet (London, England), 1964, Feb-29, Volume: 1, Issue:7331

    Topics: Abnormalities, Drug-Induced; Acetaminophen; Acetazolamide; Anti-Bacterial Agents; Cardiovascular Age

1964
MATERNAL DRUG THERAPY AND CONGENITAL CATARACTS.
    The Medical journal of Australia, 1964, Feb-08, Volume: 1

    Topics: Abnormalities, Drug-Induced; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Antipyreti

1964